Tiroid Onkositik Karsinomu

Synopsis

Tiroid onkositik karsinomu sıklıkla foliküler kansere benzer bir klinik görünüme ve benzer uzak metastaz lokalizasyonuna neden olur. Ancak klinik ve moleküler çalışmalar ayrı bir tümör tipi olduğunu açıkça göstermektedir .Foliküler kansere göre daha kötü prognoza sahip olduğu düşünülmektedir. Tedavisi ve takibi tiroid foliküler kanserine benzer şekilde yapılmaktadır.

Thyroid oncocytic carcinoma often causes a clinical appearance similar to follicular cancer and similar distant metastasis localization. However, clinical and molecular studies clearly show that it is a separate tumor type. It is thought to have a worse prognosis than follicular cancer. Treatment and follow-up are similar to thyroid follicular cancer.

References

Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumours: pathology and genetics of tumours of endocrine organs. 4th ed. Lyon: IARC; 2017.
Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2009; 19:1159.
Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid 2012; 22:690.
Kushchayeva Y, Duh QY, Kebebew E, et al. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg 2008; 195:457.
Grebe SK, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995; 24:761.

Published

June 25, 2024

License

License

How to Cite

1.
Gül G. Tiroid Onkositik Karsinomu. In: Aydın C, Değirmenci M, editors. Tiroid Kanserlerine Güncel Yaklaşım [Internet]. Türkiye: Academician Publishing Book DOI Portal; 2024 [cited 2026 Jul. 12]. pp. 99-100. Available from: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/3090/chapter/12968